Search research articles
Contact Us
Filters
Showing results (1201-1210 of 1,276) with videos related to
Page
of 128
Sort By:
Human Gene Therapy
|
December 6, 2012
AAV-mediated gene therapy in the guanylate cyclase (RetGC1/RetGC2) double knockout mouse model of Leber congenital amaurosis
Sanford L Boye, Igor V Peshenko, Wei Chieh Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 28, 2018
OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer
T Y Seiwert, C C Foster, E A Blair, et al.
Journal of Medicinal Chemistry
|
December 24, 1997
Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists
M Rowley, J J Kulagowski, A P Watt, et al.
American Heart Journal
|
February 16, 2010
Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound
Takashi Kubo, Akiko Maehara, Gary S Mintz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 13, 2015
GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD
Lesley A Inker, Hocine Tighiouart, Josef Coresh, et al.
BMC Psychiatry
|
April 16, 2020
Internet-guided cognitive, behavioral and chronobiological interventions in depression-prone insomnia subtypes: protocol of a randomized controlled prevention trial
Jeanne Leerssen, Jessica C Foster-Dingley, Oti Lakbila-Kamal, et al.
Frontiers in Neurology
|
July 3, 2025
Comparative effectiveness of epilepsy surgery versus additional anti-seizure medications for Lennox-Gastaut syndrome: study protocol for a multicenter, mixed-methods study
Sandi Lam, Marc Rosenman, Tracy Dixon-Salazar, et al.
American Journal of Hematology
|
June 23, 2021
Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results
Pramod K Mistry, Elena Lukina, Hadhami Ben Turkia, et al.
Journal of Medicinal Chemistry
|
November 13, 2007
Design, synthesis, in vitro, and in vivo characterization of phenylpiperazines and pyridinylpiperazines as potent and selective antagonists of the melanocortin-4 receptor
Joe A Tran, Wanlong Jiang, Fabio C Tucci, et al.
Diabetes Care
|
July 12, 2014
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
Jenise C Wong, Nicole C Foster, David M Maahs, et al.
Page
of 128
Search research articles
Search
Showing results (1201-1210 of 1,276) with videos related to
Sort By:
Page
of 128
Human Gene Therapy
|
December 6, 2012
AAV-mediated gene therapy in the guanylate cyclase (RetGC1/RetGC2) double knockout mouse model of Leber congenital amaurosis
Sanford L Boye, Igor V Peshenko, Wei Chieh Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 28, 2018
OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer
T Y Seiwert, C C Foster, E A Blair, et al.
Journal of Medicinal Chemistry
|
December 24, 1997
Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists
M Rowley, J J Kulagowski, A P Watt, et al.
American Heart Journal
|
February 16, 2010
Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound
Takashi Kubo, Akiko Maehara, Gary S Mintz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 13, 2015
GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD
Lesley A Inker, Hocine Tighiouart, Josef Coresh, et al.
BMC Psychiatry
|
April 16, 2020
Internet-guided cognitive, behavioral and chronobiological interventions in depression-prone insomnia subtypes: protocol of a randomized controlled prevention trial
Jeanne Leerssen, Jessica C Foster-Dingley, Oti Lakbila-Kamal, et al.
Frontiers in Neurology
|
July 3, 2025
Comparative effectiveness of epilepsy surgery versus additional anti-seizure medications for Lennox-Gastaut syndrome: study protocol for a multicenter, mixed-methods study
Sandi Lam, Marc Rosenman, Tracy Dixon-Salazar, et al.
American Journal of Hematology
|
June 23, 2021
Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results
Pramod K Mistry, Elena Lukina, Hadhami Ben Turkia, et al.
Journal of Medicinal Chemistry
|
November 13, 2007
Design, synthesis, in vitro, and in vivo characterization of phenylpiperazines and pyridinylpiperazines as potent and selective antagonists of the melanocortin-4 receptor
Joe A Tran, Wanlong Jiang, Fabio C Tucci, et al.
Diabetes Care
|
July 12, 2014
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
Jenise C Wong, Nicole C Foster, David M Maahs, et al.
Page
of 128